Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ)
CNY 4.21
(-0.94%)
CNY 4.21
(-0.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 552.79 Million | -939.12 Million | 120.63 Million | -32.39 Million | 116.33 Million | 114.11 Million |
| Net Income | -661.13 Million | -1.25 Billion | 421.64 Million | 342.6 Million | 653.75 Million | 111.34 Million |
| Depreciation & Amortization | 222.54 Million | 231.3 Million | 199.77 Million | 170.59 Million | 154.76 Million | 23.44 Million |
| Deferred income taxes | 137.32 Million | -265.07 Million | -57.61 Million | 10.3 Million | -38.99 Million | -40.98 Million |
| Stock-based compensation | - | - | -5.56 Million | 5.56 Million | - | - |
| Change in working capital | 621.68 Million | -9.1 Million | -721.16 Million | -703.72 Million | -789.95 Million | -22.21 Million |
| Other non-cash items | 83.04 Million | 96.65 Million | 283.55 Million | 142.25 Million | 97.76 Million | 1.54 Million |
| Investing Cash Flow | 906.95 Million | -119.18 Million | -428.42 Million | 107.94 Million | -747.74 Million | -284.74 Million |
| Investments in PPE | -242.38 Million | -194.81 Million | -309.02 Million | -360.75 Million | -580.58 Million | -187.87 Million |
| Acquisitions | 42.28 Million | -1.92 Million | -4.58 Million | 22.74 Million | -320 Million | -309.78 Million |
| Investment purchases | -24 Million | -76.92 Million | -137.71 Million | -139.32 Million | -1.4 Billion | -100 Million |
| Sales/Maturities of investments | 36.97 Million | 146.07 Million | 56.52 Million | 631.57 Million | 1.53 Billion | 2.93 Million |
| Other Investing Activities | 1.09 Billion | 8.41 Million | -33.61 Million | -46.29 Million | 27.65 Million | 309.97 Million |
| Financing Cash Flow | -1.71 Billion | 384.97 Million | 789.53 Million | 130.7 Million | 615.6 Million | 365.09 Million |
| Debt repayment | -2.23 Billion | -2.24 Billion | -847.37 Million | -775 Million | -478.69 Million | -72.39 Million |
| Dividends payments | -76.78 Million | -14.94 Million | -54.85 Million | -72.35 Million | -59.5 Million | -21.36 Million |
| Common Stock Repurchased | - | -40.65 Million | -30.13 Million | - | - | - |
| Common Stock Issuance | - | 40.65 Million | 30.13 Million | - | - | - |
| Other Financing Activities | 532.5 Million | 2.76 Billion | 1.76 Billion | 1.04 Billion | 1.15 Billion | 458.84 Million |
| Accounts receivables | 791.71 Million | 689.64 Million | -733.09 Million | -483.78 Million | -1.02 Billion | -370.67 Million |
| Accounts payables | -365.76 Million | -381.63 Million | 139.91 Million | -300.33 Million | 276.7 Million | -35.47 Million |
| Inventory | 168.46 Million | -52.03 Million | -70.36 Million | 70.78 Million | -4.17 Million | -18.28 Million |
| Other working capital | 27.26 Million | -265.07 Million | -57.61 Million | 9.6 Million | -38.99 Million | -3.92 Million |
| Cash at beginning of period | 1.43 Billion | 1.49 Billion | 1.01 Billion | 825.93 Million | 836.34 Million | 122.72 Million |
| Cash at end of period | 692.89 Million | 834.35 Million | 1.49 Billion | 1.01 Billion | 825.93 Million | 319.43 Million |
| Capital Expenditure | -242.38 Million | -194.81 Million | -309.02 Million | -360.75 Million | -580.58 Million | -187.87 Million |
| Effect of forex changes on cash | 2.17 Million | 14.09 Million | -1.13 Million | -19.29 Million | 5.39 Million | 2.24 Million |
| Net cash flow / Change in cash | -740.9 Million | -659.23 Million | 480.61 Million | 186.95 Million | -10.41 Million | 196.7 Million |
| Free Cash Flow | 310.4 Million | -1.13 Billion | -188.39 Million | -393.15 Million | -464.25 Million | -73.75 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -176.66 Million | -52.04 Million | -36.66 Million | -661.13 Million | -431.62 Million | -102.62 Million |
| Depreciation & Amortization | - | 53.83 Million | 53.83 Million | 222.54 Million | 51.91 Million | -114.11 Million |
| Deferred income taxes | - | - | - | 137.32 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -63.73 Million | - | 621.68 Million | 960.17 Million | -429.05 Million |
| Other non-cash items | 159.4 Million | 56.76 Million | -59.4 Million | 83.04 Million | 632.88 Million | 829.89 Million |
| Investing Cash Flow | -22.39 Million | 31.56 Million | 9.18 Million | 906.95 Million | -75.45 Million | 182.07 Million |
| Investments in PPE | -27.32 Million | -50.22 Million | -13.31 Million | -242.38 Million | -82.36 Million | -92.03 Million |
| Acquisitions | 3.05 Million | 79.47 Million | 19.5 Million | 42.28 Million | 12.38 Million | 30 Thousand |
| Investment purchases | - | -2.05 Million | -3.75 Million | -24 Million | -3 Million | -9 Million |
| Sales/Maturities of investments | - | 2.05 Million | 6.75 Million | 36.97 Million | -486.75 Thousand | 11.41 Million |
| Other Investing Activities | 1.87 Million | 2.3 Million | 22.51 Million | 1.09 Billion | -1.99 Million | 271.65 Million |
| Financing Cash Flow | -135.03 Million | -46.78 Million | 84.03 Million | -1.71 Billion | -225.39 Million | -569.14 Million |
| Debt repayment | -47.5 Million | -31.4 Million | -133.83 Million | -2.23 Billion | -933.5 Million | -969.55 Million |
| Dividends payments | - | -14.96 Million | -16.28 Million | -76.78 Million | -19.93 Million | -11.32 Million |
| Common Stock Repurchased | 99.99 Million | -99.99 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -187.51 Million | -62.25 Million | -49.79 Million | 532.5 Million | 723.76 Million | 411.73 Million |
| Accounts receivables | - | -22.04 Million | - | 791.71 Million | 791.71 Million | -323.4 Million |
| Accounts payables | - | - | - | -365.76 Million | - | - |
| Inventory | - | -41.68 Million | - | 168.46 Million | 168.46 Million | -105.64 Million |
| Other working capital | - | - | - | 27.26 Million | 27.26 Million | - |
| Cash at beginning of period | 898.31 Million | 578.52 Million | 692.89 Million | 1.43 Billion | 963.86 Million | 938.89 Million |
| Cash at end of period | 682.81 Million | 515.35 Million | 723.87 Million | 692.89 Million | 692.89 Million | 734.4 Million |
| Capital Expenditure | -27.32 Million | -50.22 Million | -13.31 Million | -242.38 Million | -82.36 Million | -92.03 Million |
| Effect of forex changes on cash | - | 1.17 Million | 1.43 Million | 2.17 Million | -2.94 Million | -1.52 Million |
| Net cash flow / Change in cash | -215.5 Million | -63.17 Million | 30.97 Million | -740.9 Million | -270.96 Million | -204.49 Million |
| Free Cash Flow | -44.58 Million | -99.34 Million | -109.38 Million | 310.4 Million | 66.97 Million | 92.07 Million |
8410
RMBL
BBDC4
VAN
VBIND
0309